ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $152,272 | -99.9% | 7,606 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $196,463,000 | +54.7% | 7,606 | +43.2% | 0.00% | +50.0% |
| Q1 2018 | $126,981,000 | +70445.0% | 5,313 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $180,000 | -18.6% | 5,313 | -49.1% | 0.00% | +100.0% |
| Q3 2017 | $221,000 | +21.4% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $182,000 | 0.0% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $182,000 | +3.4% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $176,000 | +2.9% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $171,000 | +8.2% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $158,000 | +18.8% | 10,428 | +31.6% | 0.00% | 0.0% |
| Q3 2015 | $133,000 | -36.1% | 7,926 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $208,000 | – | 7,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
| Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
| Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
| Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
| ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
| NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
| Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
| Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |